- Home
- EVGO vs PRTA Comparison
EVGO vs PRTA Comparison
Compare EVGO & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGO
- PRTA
- Stock Information
- Founded
- EVGO 2010
- PRTA 2012
- Country
- EVGO United States
- PRTA Ireland
- Employees
- EVGO N/A
- PRTA N/A
- Industry
- EVGO Other Specialty Stores
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- EVGO Consumer Discretionary
- PRTA Health Care
- Exchange
- EVGO Nasdaq
- PRTA Nasdaq
- Market Cap
- EVGO 686.0M
- PRTA 643.0M
- IPO Year
- EVGO N/A
- PRTA N/A
- Fundamental
- Price
- EVGO $3.31
- PRTA $14.11
- Analyst Decision
- EVGO Strong Buy
- PRTA Buy
- Analyst Count
- EVGO 10
- PRTA 7
- Target Price
- EVGO $6.61
- PRTA $46.50
- AVG Volume (30 Days)
- EVGO 5.4M
- PRTA 672.2K
- Earning Date
- EVGO 03-05-2025
- PRTA 02-13-2025
- Dividend Yield
- EVGO N/A
- PRTA N/A
- EPS Growth
- EVGO N/A
- PRTA N/A
- EPS
- EVGO N/A
- PRTA N/A
- Revenue
- EVGO $239,306,000.00
- PRTA $133,350,000.00
- Revenue This Year
- EVGO $63.89
- PRTA $56.89
- Revenue Next Year
- EVGO $38.45
- PRTA N/A
- P/E Ratio
- EVGO N/A
- PRTA N/A
- Revenue Growth
- EVGO 73.08
- PRTA N/A
- 52 Week Low
- EVGO $1.65
- PRTA $11.70
- 52 Week High
- EVGO $9.07
- PRTA $34.65
- Technical
- Relative Strength Index (RSI)
- EVGO 25.47
- PRTA 50.40
- Support Level
- EVGO $3.71
- PRTA $13.00
- Resistance Level
- EVGO $4.00
- PRTA $14.40
- Average True Range (ATR)
- EVGO 0.24
- PRTA 0.99
- MACD
- EVGO -0.02
- PRTA 0.04
- Stochastic Oscillator
- EVGO 9.77
- PRTA 59.11
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the us. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the us. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).